vs
趣店（HTT）与波士顿科学（MLSS）财务数据对比。点击上方公司名可切换其他公司
波士顿科学的季度营收约是趣店的1.9倍（$2.1M vs $1.1M），趣店净利率更高（239.8% vs -53.0%，领先292.8%）
趣店集团是中国本土金融科技服务提供商，核心业务涵盖小额消费信贷解决方案输出、风险管理技术服务及相关数字金融产品供应，主要服务国内广大年轻消费群体，业务布局集中于中国内地市场。
波士顿科学公司是源自美国的跨国生物医疗企业，专业研发生产介入医疗领域医疗器械，产品覆盖介入放射学、介入心脏病学、外周介入治疗、神经调控、神经血管介入、电生理、心脏外科、血管外科、内镜、肿瘤学、泌尿与妇科等多个领域。
HTT vs MLSS — 直观对比
营收规模更大
MLSS
是对方的1.9倍
$1.1M
净利率更高
HTT
高出292.8%
-53.0%
损益表 — Q3 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $2.1M |
| 净利润 | $2.6M | $-1.1M |
| 毛利率 | 11.1% | 73.0% |
| 营业利润率 | -121.7% | -52.5% |
| 净利率 | 239.8% | -53.0% |
| 营收同比 | — | 2.2% |
| 净利润同比 | — | 46.4% |
| 每股收益（稀释后） | $0.01 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTTMLSS
| Q4 25 | — | $2.1M | ||
| Q3 25 | — | $2.4M | ||
| Q2 25 | — | $2.3M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | $1.1M | $2.5M | ||
| Q2 24 | $1.0M | $1.9M | ||
| Q1 24 | $1.1M | $2.2M |
净利润HTTMLSS
| Q4 25 | — | $-1.1M | ||
| Q3 25 | — | $-1.2M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-2.0M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | $2.6M | $-1.5M | ||
| Q2 24 | $1.9M | $223.6K | ||
| Q1 24 | $-1.4M | $-1.4M |
毛利率HTTMLSS
| Q4 25 | — | 73.0% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 69.6% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | 75.0% | ||
| Q3 24 | 11.1% | 73.0% | ||
| Q2 24 | 13.3% | 76.1% | ||
| Q1 24 | — | 74.5% |
营业利润率HTTMLSS
| Q4 25 | — | -52.5% | ||
| Q3 25 | — | -48.1% | ||
| Q2 25 | — | -63.9% | ||
| Q1 25 | — | -89.5% | ||
| Q4 24 | — | -101.4% | ||
| Q3 24 | -121.7% | -58.4% | ||
| Q2 24 | -107.6% | -96.0% | ||
| Q1 24 | -129.9% | -65.1% |
净利率HTTMLSS
| Q4 25 | — | -53.0% | ||
| Q3 25 | — | -48.9% | ||
| Q2 25 | — | -63.8% | ||
| Q1 25 | — | -89.3% | ||
| Q4 24 | — | -101.1% | ||
| Q3 24 | 239.8% | -58.1% | ||
| Q2 24 | 187.1% | 12.1% | ||
| Q1 24 | -131.8% | -64.1% |
每股收益（稀释后）HTTMLSS
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.01 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0.01 | $-0.02 | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $104.9M | $1.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $225.2M | $2.8M |
| 总资产 | $246.8M | $7.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HTTMLSS
| Q4 25 | — | $1.1M | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $104.9M | $4.8M | ||
| Q2 24 | $112.8M | $5.8M | ||
| Q1 24 | $140.6M | $5.0M |
股东权益HTTMLSS
| Q4 25 | — | $2.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $225.2M | $7.2M | ||
| Q2 24 | $217.5M | $8.0M | ||
| Q1 24 | $218.9M | $7.5M |
总资产HTTMLSS
| Q4 25 | — | $7.8M | ||
| Q3 25 | — | $8.5M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $9.1M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $246.8M | $11.2M | ||
| Q2 24 | $227.9M | $12.0M | ||
| Q1 24 | $234.9M | $11.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-226.1K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流HTTMLSS
| Q4 25 | — | $-226.1K | ||
| Q3 25 | — | $81.8K | ||
| Q2 25 | — | $-1.8M | ||
| Q1 25 | — | $-1.0M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | — | $-973.9K | ||
| Q2 24 | — | $783.7K | ||
| Q1 24 | — | $-1.2M |
现金转化率HTTMLSS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.50× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
